title: Use of anti-X a activity as a marker for heparin-induced bleeding in patients with APTT > 180 s.
authors.affiliation: Clin. Labs, Onassis Cardiac Surgery Center, Kallithea, Greece. mdb1@hol.gr
authors.forename: A
authors.initials: A
authors.lastname: Haliassos
authors.forename: H
authors.initials: H
authors.lastname: Melita-Manolis
authors.forename: D
authors.initials: D
authors.lastname: Aggelaki
authors.forename: D
authors.initials: D
authors.lastname: Tassi
authors.forename: G
authors.initials: G
authors.lastname: Terzoglou
mesh_terms: D000328:Adult; D000368:Aged; D016903:Drug Monitoring / Q000379:methods; D065427:Factor Xa Inhibitors; D006470:Hemorrhage / Q000139:chemically induced* / Q000209:etiology; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D010314:Partial Thromboplastin Time; D013923:Thromboembolism / Q000188:drug therapy* / Q000517:prevention & control
chemical_list: D065427:Factor Xa Inhibitors; D006493:Heparin